Clinical Roundup NCI-designated subspecialist reviews improve 94% of pancreatic cancer treatment paths October 27, 2023Vol.49 No.40
Clinical Roundup UC Davis researchers identify “switch” to activate cancer cell death October 27, 2023Vol.49 No.40
Clinical Roundup SWOG: Major pathologic response to neoadjuvant Keytruda in advanced melanoma trial exceeds 50% October 27, 2023Vol.49 No.40
Clinical Roundup Taletrectinib shrinks tumors in NSCLC indication in phase II trial October 27, 2023Vol.49 No.40
Clinical Roundup Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer October 27, 2023Vol.49 No.40
Clinical Roundup PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find October 27, 2023Vol.49 No.40
Clinical Roundup USC study reveals how exposure to racial discrimination can impact health care for Black cancer patients October 27, 2023Vol.49 No.40
Clinical Roundup Cedars-Sinai researchers find two potential treatments that improve outcomes in recurrent prostate cancer October 27, 2023Vol.49 No.40
Clinical Roundup Five-year monarchE outcome data demonstrate Verzenio’s long-term impact on cancer recurrence in high-risk early breast cancer October 27, 2023Vol.49 No.40
Clinical Roundup mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma October 27, 2023Vol.49 No.40
